Mark Andersen, CFA and CPA, most recently served as Vice President Finance and Corporate Controller for a biomedical company in Georgia. In that role, he was responsible for SEC reporting, mergers and acquisitions valuations and diligence, accounts payable, payroll, controls, and the employee retirement plan.
Previously, Andersen held multiple financial leadership roles at Eli Lilly and Company, including Investments Director for the company’s pension plan, where he managed highly diversified investment portfolios totaling approximately $13 billion in assets. He also served as Finance Director for Mergers & Acquisitions, where he completed acquisitions of both domestic and international businesses, and provided financial leadership and negotiation support for licensing and business development transactions. As Finance Director and Controller for Lilly USA, Andersen led the financial planning and analysis team of Lilly's U.S. sales and marketing affiliate with more than $10 billion in annual sales, and served as its financial controller with oversight for accounting and internal controls. He started his career in public accounting as an auditor with firms KPMG and Deloitte.
Andersen received his Bachelor of Science degree in accounting and Master of Science in accountancy from Southern Utah University, graduating magna cum laude and with high distinction. He earned his MBA from the University of Michigan Ross School of Business.